These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 9296470)

  • 21. [Platelet glycoprotein IIb/IIIa inhibitors in coronary artery disease].
    Auer J; Berent R; Lassnig E; Weber T; Maurer E; Eber B
    Herz; 2003 Aug; 28(5):393-403. PubMed ID: 12928738
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An overview of the results of clinical trials with glycoprotein IIb/IIIa inhibitors.
    Adgey AA
    Eur Heart J; 1998 Apr; 19 Suppl D():D10-21. PubMed ID: 9597518
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antiplatelet intervention in acute coronary syndrome.
    Arora RR; Rai F
    Am J Ther; 2009; 16(5):e29-40. PubMed ID: 19092648
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Timing of angiography with a routine invasive strategy and long-term outcomes in non-ST-segment elevation acute coronary syndrome: a collaborative analysis of individual patient data from the FRISC II (Fragmin and Fast Revascularization During Instability in Coronary Artery Disease), ICTUS (Invasive Versus Conservative Treatment in Unstable Coronary Syndromes), and RITA-3 (Intervention Versus Conservative Treatment Strategy in Patients With Unstable Angina or Non-ST Elevation Myocardial Infarction) Trials.
    Damman P; van Geloven N; Wallentin L; Lagerqvist B; Fox KA; Clayton T; Pocock SJ; Hirsch A; Windhausen F; Tijssen JG; de Winter RJ
    JACC Cardiovasc Interv; 2012 Feb; 5(2):191-9. PubMed ID: 22361604
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characteristics, treatment and outcome of patients with non-ST-elevation acute coronary syndromes and multivessel coronary artery disease: observations from PURSUIT (platelet glycoprotein IIb/IIIa in unstable angina: receptor suppression using integrelin therapy).
    Breeman A; Mercado N; Lenzen M; van den Brand MM; Harrington RA; Califf RM; Topol EJ; Simoons ML; Boersma E;
    Cardiology; 2002; 98(4):195-201. PubMed ID: 12566649
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of completeness of revascularization on clinical outcome in patients with multivessel disease presenting with unstable angina who undergo percutaneous coronary intervention.
    Palmer ND; Causer JP; Ramsdale DR; Perry RA
    J Invasive Cardiol; 2004 Apr; 16(4):185-8. PubMed ID: 15152143
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Outcome after combined reperfusion therapy for acute myocardial infarction, combining pre-hospital thrombolysis with immediate percutaneous coronary intervention and stent.
    Loubeyre C; Lefèvre T; Louvard Y; Dumas P; Piéchaud JF; Lanore JJ; Angellier JF; Le Tarnec JY; Karrillon G; Margenet A; Pougès C; Morice MC
    Eur Heart J; 2001 Jul; 22(13):1128-35. PubMed ID: 11428853
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Management and outcome of patients with established coronary artery disease: the Euro Heart Survey on coronary revascularization.
    Lenzen MJ; Boersma E; Bertrand ME; Maier W; Moris C; Piscione F; Sechtem U; Stahle E; Widimsky P; de Jaegere P; Scholte op Reimer WJ; Mercado N; Wijns W;
    Eur Heart J; 2005 Jun; 26(12):1169-79. PubMed ID: 15802360
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Early vs late administration of glycoprotein IIb/IIIa inhibitors in primary percutaneous coronary intervention of acute ST-segment elevation myocardial infarction: a meta-analysis.
    Montalescot G; Borentain M; Payot L; Collet JP; Thomas D
    JAMA; 2004 Jul; 292(3):362-6. PubMed ID: 15265852
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Combining enoxaparin and glycoprotein IIb/IIIa antagonists for the treatment of acute coronary syndromes: final results of the National Investigators Collaborating on Enoxaparin-3 (NICE-3) study.
    Ferguson JJ; Antman EM; Bates ER; Cohen M; Every NR; Harrington RA; Pepine CJ; Theroux P;
    Am Heart J; 2003 Oct; 146(4):628-34. PubMed ID: 14564315
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Prognosis after acute coronary syndrome. Lack of difference according to the sex].
    Bounhoure JP; Farah B; Fajadet J; Marco J
    Bull Acad Natl Med; 2004; 188(3):383-97; discussion 397-9. PubMed ID: 15584651
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of medicine alone, coronary angioplasty, and left internal mammary artery-coronary artery bypass for one-vessel proximal left anterior descending coronary artery disease.
    Greenbaum AB; Califf RM; Jones RH; Gardner LH; Phillips HR; Sketch MH; Stack RS; Puma JA
    Am J Cardiol; 2000 Dec; 86(12):1322-6. PubMed ID: 11113406
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Early aggressive treatment of unstable angina without on-site cardiac surgical facilities: a prospective study of acute and long-term outcome.
    Ferrero V; Steffenino G; Meinardi F; Conte E; Deorsola A; Vado A; Racca E; Dellavalle A; Ribichini F; Menardi E; Uslenghi E
    G Ital Cardiol; 1998 Feb; 28(2):112-9. PubMed ID: 9534050
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of time-to-treatment on myocardial perfusion after primary percutaneous coronary intervention with Gp IIb-IIIa inhibitors.
    De Luca G; Gibson MC; Hof AW; Cutlip D; Zeymer U; Noc M; Maioli M; Zorman S; Gabriel MH; Secco GG; Emre A; Dudek D; Rakowski T; Gyongyosi M; Huber K; Bellandi F;
    J Cardiovasc Med (Hagerstown); 2013 Nov; 14(11):815-20. PubMed ID: 23519096
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Frequency and efficacy of glycoprotein IIb/IIIa therapy for treatment of threatened or acute vessel closure in 1332 patients undergoing percutaneous transluminal coronary angioplasty.
    Haase KK; Mahrholdt H; Schröder S; Baumbach A; Oberhoff M; Herdeg C; Karsch KR
    Am Heart J; 1999 Feb; 137(2):234-40. PubMed ID: 9924156
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Invasive versus conservative strategy in patients aged 80 years or older with non-ST-elevation myocardial infarction or unstable angina pectoris (After Eighty study): an open-label randomised controlled trial.
    Tegn N; Abdelnoor M; Aaberge L; Endresen K; Smith P; Aakhus S; Gjertsen E; Dahl-Hofseth O; Ranhoff AH; Gullestad L; Bendz B;
    Lancet; 2016 Mar; 387(10023):1057-1065. PubMed ID: 26794722
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Angiographic and clinical outcomes of bivalirudin versus heparin in patients with acute coronary syndrome undergoing percutaneous coronary intervention.
    Matar F; Donoghue C; Rossi P; Vandormael M; Sullebarger JT; Kerenski R; Jauch W; Gloer K; Ebra G
    Can J Cardiol; 2006 Nov; 22(13):1139-45. PubMed ID: 17102832
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Timing of angiography and revascularization in acute coronary syndromes: an analysis of the TACTICS-TIMI-18 trial.
    McCullough PA; Gibson CM; Dibattiste PM; Demopoulos LA; Murphy SA; Weintraub WS; Neumann FJ; Khanal S; Cannon CP;
    J Interv Cardiol; 2004 Apr; 17(2):81-6. PubMed ID: 15104769
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The continuing debate: conservative or interventional therapy for unstable coronary artery disease.
    Hillis WS
    Am J Cardiol; 1997 Sep; 80(5A):51E-54E. PubMed ID: 9296471
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acute coronary syndromes: extending medical intervention for five days before proceeding to revascularization.
    Holmes DR
    Am J Cardiol; 2000 Dec; 86(12B):36M-41M. PubMed ID: 11206017
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.